R. Ramelmeier
Technik-/Wissenschafts-/F&E-Leiter bei ADVERUM BIOTECHNOLOGIES, INC.
Vermögen: 44 304 $ am 30.04.2024
Aktive Positionen von R. Ramelmeier
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ADVERUM BIOTECHNOLOGIES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 21.08.2023 | - |
Karriereverlauf von R. Ramelmeier
Ehemalige bekannte Positionen von R. Ramelmeier
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SANGAMO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | 10.07.2023 |
Corporate Officer/Principal | 01.01.2018 | - | |
PORTOLA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2014 | 01.01.2017 |
BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01.01.2006 | 01.01.2014 |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Corporate Officer/Principal | 01.01.2001 | 01.01.2005 |
JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
Ausbildung von R. Ramelmeier
University of California, Berkeley | Doctorate Degree |
The Johns Hopkins University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Operativ
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
SANGAMO THERAPEUTICS, INC. | Health Technology |
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
JOHNSON & JOHNSON | Health Technology |
ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
- Börse
- Insiders
- R. Ramelmeier
- Erfahrung